Shares of Health Care sector company Boston Scientific moved 1.6% today, and are now trading at a price of $96.01. The Large-Cap stock's daily volume was 11,893,428 compared to its average volume of 9,719,490. The S&P 500 index returned a 1.0% performance.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company is based in Marlborough and has 53,000 full time employees. Its market capitalization is $142,329,266,176.
31 analysts are following Boston Scientific and have set target prices ranging from $99.0 to $140.0 per share. On average, they have given the company a rating of buy. At today's prices, BSX is trading -23.79% away from its average analyst target price of $125.98 per share.
Over the last year, BSX's share price has increased by 6.6%, which represents a difference of -8.0% when compared to the S&P 500. The stock's 52 week high is $109.5 per share whereas its 52 week low is $85.98. With average free cash flows of $1.53 Billion that have been growing at an average rate of 16.1% over the last 5 years, Boston Scientific is in a position to continue its strong stock performance trend.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 3,435,000 | 790,000 | 2,645,000 | 47.6 |
| 2023 | 2,503,000 | 711,000 | 1,792,000 | 91.04 |
| 2022 | 1,526,000 | 588,000 | 938,000 | -28.72 |
| 2021 | 1,870,000 | 554,000 | 1,316,000 | 16.25 |
| 2020 | 1,508,000 | 376,000 | 1,132,000 | -17.67 |
| 2019 | 1,836,000 | 461,000 | 1,375,000 |
